You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 15, 2026

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
Published on: October 6, 2023
Yoshimasa Tanaka1, Haruki Okamura
1Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University.
Human gammadeltaT cells show promise in cancer immunotherapy by targeting tumor cells. Interleukin-18 (IL-18) aids in expanding these crucial immune cells, offering new therapeutic avenues.
Area of Science: